PTD-DBM + VALPROIC ACID - 30ml /5mg + 30ml/450mg

ADVANCED DELIVERY SYSTEM - STRUCTURED CARRIER TECHNOLOGY

This product utilizes a structured topical delivery architecture integrating membrane-interactive carrier matrices with controlled CPP-assisted transport modulation. The formulation is engineered according to the physicochemical profile of the research compound to support membrane interaction, diffusion behavior, and preservation of molecular integrity.

SPECIFICATIONS

Product Code: PDV005T

PTD-DBM - 5 mg

Sequence: RRRRRRRRGGGGRKTGHQICKFRKC

Molecular Formula: C134H244N60O32S2

Molecular Weight: 3082.65 g/mol

CAS: N/A

Purity: Technical / Research Grade ≥98%

Form: Liquid Solution

Appearance: Clear to slightly opalescent

Total Content: 30 mL / 5 mg

Concentration: 0.167 mg/mL

Vehicle / Carrier System: Proprietary carrier system

Storage Temperature: 4°C (Do not freeze)

Source: Synthetic

Safety Classification: Standard laboratory handling

VALPROIC ACID - 450 mg (1.5%)

Molecular Formula: C8H16O2

Molecular Weight: 144.21 g/mol

CAS: 99-66-1

Purity: Technical / Research Grade ≥99%

Form: Liquid Solution

Appearance: Colorless to slightly yellow

Storage Temperature: 15–25°C

Source: Synthetic

Safety Classification: Standard laboratory handling

DESCRIPTION

PTD-DBM is an acronym for Protein Transduction Domain – Dishevelled Binding Motif. It is a synthetic chimeric peptide engineered to interact with intracellular signaling pathways associated with hair follicle biology. This peptide combines two functional components:

• A protein transduction domain (PTD), typically composed of a poly-arginine sequence that facilitates cellular uptake.

• A Dvl-binding motif (DBM), designed to interfere with the interaction between specific regulatory proteins involved in Wnt signaling.

PTD-DBM is investigated in experimental models as a biochemical modulator of hair follicle signaling pathways.

• It is not a hormone.
• It is not a growth factor.
• It is not a direct stimulator of proliferation.

Rather, it functions as a signaling interaction modulator.

Biological Background: Hair Follicle Signaling

Hair follicle development, cycling, and regeneration are strongly influenced by the Wnt/β-catenin signaling pathway. The Wnt pathway regulates:

• Stem cell activation

• Transition from telogen (resting phase) to anagen (growth phase)

• Dermal papilla cell activity

• Follicular morphogenesis

• Tissue regeneration

Wnt signaling involves coordinated communication between membrane receptors, cytoplasmic proteins, and transcription factors. One of the critical regulatory checkpoints within this pathway involves the interaction between:

• CXXC-type zinc finger protein 5 (CXXC5)

• Dishevelled protein (Dvl)

The Role of CXXC5 in Follicular Regulation

CXXC5 has been identified in experimental literature as a negative regulator of Wnt/β-catenin signaling. When CXXC5 binds to Dishevelled (Dvl), it:

• Inhibits downstream Wnt activation

• Reduces β-catenin stabilization

• Suppresses transcription of Wnt target genes

• Limits follicular activation

This regulatory mechanism appears to function as a negative feedback loop within the follicle. In androgenetic alopecia models, increased CXXC5 activity has been associated with reduced follicular regenerative signaling.

Mechanism of PTD-DBM

PTD-DBM is designed as a competitive inhibitor of the CXXC5–Dvl interaction. After cellular internalization via its protein transduction domain, the DBM portion of the peptide:

• Binds to Dishevelled

• Prevents CXXC5 from interacting with Dvl

• Reduces inhibitory signaling

• Supports restoration of Wnt pathway activity

By disrupting this inhibitory complex, PTD-DBM allows β-catenin signaling to proceed more effectively in experimental systems. Importantly, PTD-DBM does not artificially activate Wnt signaling. Instead, it reduces suppression. This distinction is critical for safety and regulatory context.

Experimental Observations in Preclinical Models

In CXXC5-deficient murine models:

• Enhanced transition from telogen to anagen was observed

• Increased β-catenin levels were detected

• Elevated alkaline phosphatase expression was noted

• Proliferating cell nuclear antigen (PCNA) levels increased

These markers are commonly associated with follicular activation and regenerative signaling. Loss of CXXC5 function appeared to support hair cycling progression.

Valproic Acid (VPA) as a Synergistic Signaling Modulator

Valproic acid is a branched-chain fatty acid investigated in dermatological research for its ability to influence signaling pathways associated with hair biology. In cellular systems, VPA has demonstrated:

• Inhibition of GSK3β activity

• Partial Wnt pathway agonist behavior

• Modulation of histone deacetylase (HDAC) activity

• Increased β-catenin stabilization

Through GSK3β inhibition, VPA reduces β-catenin degradation, thereby supporting Wnt pathway activation. In experimental hair models, VPA has been associated with increased dermal papilla activity and follicular signaling.

Synergistic Interaction Between PTD-DBM and VPA

Preclinical experiments demonstrated that:

• PTD-DBM interferes with inhibitory binding (CXXC5–Dvl)

• VPA enhances β-catenin stabilization via GSK3β antagonism

When combined:

• Increased dermal papilla cell activity was observed

• Enhanced β-catenin signaling was detected

• Greater expression of alkaline phosphatase and PCNA was reported

• Synergistic hair regrowth effects were noted in murine models

Importantly, Wnt3a stimulation alone induced CXXC5 expression, suggesting a built-in negative feedback mechanism.

• PTD-DBM appears to counteract this feedback loop.
• VPA amplifies the permissive signaling environment.

Together, they support a regulatory shift toward follicular activation under experimental conditions.

Implications for Hair Follicle Biology

In laboratory systems, modulation of the CXXC5–Dvl interaction has been associated with:

• Promotion of anagen transition

• Increased dermal papilla signaling

• Enhanced expression of FGF9

• Elevated keratin 17 expression

• Augmented wound-induced hair neogenesis

These effects are consistent with restoration of Wnt signaling dynamics.

Conceptual Framework of the Combination

PTD-DBM acts at the level of protein-protein interaction. Valproic acid modulates intracellular kinase and epigenetic regulation. Their combined action addresses:

• Inhibitory checkpoint removal
• Signal stabilization
• Transcriptional permissiveness

This multi-layer modulation may provide a mechanistically coherent approach to follicular signaling research.

Follicular Microenvironment Considerations

Hair follicle cycling depends on:

• Stem cell niche integrity

• Dermal papilla communication

• Extracellular matrix balance

• Local inflammatory tone

By influencing Wnt pathway dynamics, PTD-DBM + VPA may contribute to:

• Support of follicular signaling networks

• Maintenance of regenerative signaling conditions

• Modulation of inhibitory feedback loops

Summary of Mechanistic Action

PTD-DBM:

• Blocks CXXC5–Dvl binding

• Reduces inhibitory Wnt feedback

• Supports β-catenin signaling restoration

Valproic Acid:

• Inhibits GSK3β

• Stabilizes β-catenin

• Modulates epigenetic transcription

Together:

• Enhance Wnt pathway signaling dynamics

• Support follicular activation markers in experimental models

• Demonstrate synergistic effects in preclinical hair regeneration studies.

REFERENCES

Soung-Hoon Lee et al., "The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing" [JEM]

Soung-Hoon Lee et al., "Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis" [ScienceDirect]

Y.C. Ryu et al., "CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD2" [MDPI]

S.J. Jo et al., "Topical valproic acid increases the hair count in male patients with androgenetic alopecia: a randomized, comparative, clinical feasibility study using phototrichogram analysis" [PubMed]

S. Lee "Molecular Signaling Pathways in Wound-Induced Hair-Follicle Neogenesis" [PMC]

Y.C. Ryu et al., "KY19382, a novel activator of Wnt/β‐catenin signalling, promotes hair regrowth and hair follicle neogenesis" [PMC]

M. Bejaoui et al., "β-catenin-mediated hair growth induction effect of 3,4,5-tri-O-caffeoylquinic acid" [PMC]

S.J. Jo et al., "Valproic acid promotes human hair growth in in vitro culture model" [PubMed]

A. Mehta et al., "Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies" [PMC]

DISCLAIMER

This product is intendend for lab research and development use only. These studies are performed outside of the body. This product is not medicines or drugs and has not been approved by the FDA or EMA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals.

All product information provided on this website is for informational and educational purposes only.

...